a16z Capital Management, L.L.C.
Q1 2026 13F Holdings
- Locationmenlo park, CA
- Num holdings
16
- Value ($000)
$1,290,612
- Date Filed 05/15/2026
- Form type13F-HR
- CIK 0001540358
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NAVAN INC | CL A | 639193101 | $373.62M | 29 % | 28,218,676 | ||
FIGMA INC | CLASS A COM STK | 316841105 | $338.48M | 26 % | 16,011,378 | ||
META PLATFORMS INC | CL A | 30303M102 | $121.6M | 9 % | 212,531 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | $89.58M | 7 % | 921,099 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | $68.5M | 5 % | 17,653,917 | ||
BLOCK INC | CL A | 852234103 | $61.18M | 5 % | 1,016,697 | ||
BIOAGE LABS INC | COM | 09077V100 | $56.55M | 4 % | 3,233,170 | ||
MAZE THERAPEUTICS INC | COM | 578784100 | $50.81M | 4 % | 1,702,225 | ||
ERASCA INC | COM | 29479A108 | $46.32M | 4 % | 2,862,500 | ||
DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | $32.02M | 3 % | 1,236,157 |
Rows Per Page
10
- 10
- 50
- 100